CompletedNot Applicable

Continous Glucose Monitoring in Neonates at Risk of Hypoglycaemia- a Feasibility Study

Norway25 participantsStarted 2023-03-01

Plain-language summary

The study's main purpose is to test feasibility of Continous Glucose montoring in Neonates during the first 72 hrs.

Who can participate

Age range0 Hours – 5 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * LGA, Maternal diabetes (TID and TIID and Gestational diabetes) * GA\>36+6 Exclusion Criteria: * SGA, Prematurity, major congenital anomalies, multiple pregnancy and severe asphyxia (Apgar \< 5 by 10 min. age).

What they're measuring

Glucose profile

Timeframe: +100hrs

Trial details

NCT IDNCT07375615

SponsorSykehuset Innlandet HF

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Hyperglycemia trials